Variables | Sensitivity (95% CI) | Specificity (95%CI) | PPV (95% CI) | NPV (95% CI) | Accuracy (95% CI) |
---|---|---|---|---|---|
Absolute criteria | |||||
Solid component | 29% (18–41) | 87% (76–94) | 69% (48–85) | 55% (44–65) | 58% (46–71) |
Whipple/Total PT | 35% | 76% | 70% | 43% | 51% |
Jaundice | 11% (4–21) | 98% (91–99) | 87% (47–99) | 52% (43–61) | 55% (44–68) |
Whipple/Total PT | 15% | 97% | 88% | 42% | 46% |
Mural Nodule | 16% (8–27) | 85% (74–99) | 53% (28–75) | 50% (40–60) | 50% (42–61) |
Whipple/Total PT | 7% | 80% | 34% | 35% | 35% |
MD ≥ 10 mm | 39% (26–51) | 84% (73–91) | 71% (52–84) | 58% (46–68) | 61% (48–79) |
Whipple/Total PT | 48% | 76% | 76% | 48% | 59% |
At least two criteria (n = 20) | 24% (14–36) | 91% (84–97) | 75% (59–91) | 55% (44–64) | 58% (44–67) |
Whipple/Total PT | 31% | 76% | 67% | 41% | 48% |
At least three criteria (n = 9) | 11% (4–21) | 97% (88–96) | 77% (40–97) | 52% (42–61) | 51% (40–60) |
Whipple/Total PT | 16% | 94% | 78% | 41% | 46% |
Relative Criteria | |||||
Cyst ≥ 4 cm (*) | 42% (29–55) | 90% (80–96) | 81% (63–93) | 61% (50–71) | 66% (54–81) |
Whipple/Total PT | 53% | 76% | 78% | 50% | 62% |
MD 5–9.9 mm | 47% (34–60) | 66% (53–77) | 58% (43–72) | 55% (43–67) | 56% (44–71) |
Whipple/Total PT | 35% | 69% | 64% | 40% | 48% |
Acute pancreatitis | 21% (11–36) | 82% (72–91) | 54% (43–66) | 51% (41–61) | 52% (43–64) |
Whipple/Total PT | 16% | 80% | 54% | 38% | 40% |
New onset of diabetes | 3% (0.4–11) | 88% (78–93) | 22% (3–60) | 48% (38–57) | 46% (39–59) |
Whipple/Total PT | 9% | 83% | 45% | 37% | 38% |
Rapid growth rate | 1% (0.3–19) | 83% (72–92) | 37% (15–64) | 48% (38–58) | 47% (36–59) |
Whipple/Total PT | 11% | 90% | 63% | 39% | 42% |
At least two criteria (n = 30) | 30% (19–43) | 82% (70–90) | 63% (43–80) | 54% (43–64) | 56% (45–68) |
Whipple/Total PT | 22% | 63% | 48% | 34% | 38% |
At least three criteria (n = 9) | 14% (5–23) | 100% (94–100) | 100% (63–100) | 54% (44–62) | 57% (45–70) |
Whipple/Total PT | 9% | 100% | 100% | 41% | 44% |